Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
European Journal of Heart Failure
|
May 29, 2018
Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysis
Michel Komajda, Michael Böhm, Jeffrey S Borer, et al.
Statistics in Medicine
|
December 15, 2018
Predictive probability of success using surrogate endpoints
Gaelle Saint-Hilary, Valentine Barboux, Matthieu Pannaux, et al.
Statistics in Medicine
|
January 31, 2022
A comparison of estimation methods adjusting for selection bias in adaptive enrichment designs with time-to-event endpoints
Fulvio Di Stefano, Matthieu Pannaux, Anne Correges, et al.
Journal of the American College of Cardiology
|
January 24, 2024
Randomized Trial of Macitentan/Tadalafil Single-Tablet Combination Therapy for Pulmonary Arterial Hypertension
Ekkehard Grünig, Pavel Jansa, Fenling Fan, et al.
Advances in Therapy
|
March 13, 2026
Long-Term Treatment with Single-Tablet Combination of Macitentan and Tadalafil in Pulmonary Arterial Hypertension: Results from A DUE and Its Open-Label Period
H James Ford, Kelly M Chin, Fenling Fan, et al.
Circulation. Heart Failure
|
June 26, 2020
Comparison of Outcome Adjudication by Investigators and by a Central End Point Committee in Heart Failure Trials: Experience of the SHIFT Heart Failure Study
Benoît Tyl, José Lopez Sendon, Jeffrey S Borer, et al.
European Journal of Heart Failure
|
May 3, 2017
Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial
Michel Komajda, Richard Isnard, Alain Cohen-Solal, et al.
The Lancet. Haematology
|
October 13, 2022
UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial
Reuben Benjamin, Nitin Jain, Marcela V Maus, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
European Journal of Heart Failure
|
May 29, 2018
Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysis
Michel Komajda, Michael Böhm, Jeffrey S Borer, et al.
Statistics in Medicine
|
December 15, 2018
Predictive probability of success using surrogate endpoints
Gaelle Saint-Hilary, Valentine Barboux, Matthieu Pannaux, et al.
Statistics in Medicine
|
January 31, 2022
A comparison of estimation methods adjusting for selection bias in adaptive enrichment designs with time-to-event endpoints
Fulvio Di Stefano, Matthieu Pannaux, Anne Correges, et al.
Journal of the American College of Cardiology
|
January 24, 2024
Randomized Trial of Macitentan/Tadalafil Single-Tablet Combination Therapy for Pulmonary Arterial Hypertension
Ekkehard Grünig, Pavel Jansa, Fenling Fan, et al.
Advances in Therapy
|
March 13, 2026
Long-Term Treatment with Single-Tablet Combination of Macitentan and Tadalafil in Pulmonary Arterial Hypertension: Results from A DUE and Its Open-Label Period
H James Ford, Kelly M Chin, Fenling Fan, et al.
Circulation. Heart Failure
|
June 26, 2020
Comparison of Outcome Adjudication by Investigators and by a Central End Point Committee in Heart Failure Trials: Experience of the SHIFT Heart Failure Study
Benoît Tyl, José Lopez Sendon, Jeffrey S Borer, et al.
European Journal of Heart Failure
|
May 3, 2017
Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial
Michel Komajda, Richard Isnard, Alain Cohen-Solal, et al.
The Lancet. Haematology
|
October 13, 2022
UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial
Reuben Benjamin, Nitin Jain, Marcela V Maus, et al.
Page
of 1